University Hospital. Parkland Hospital

Similar documents
Aortic Graft Infection- Contemporary Management of a Resurgent Problem

Prosthetic Vascular Graft Infection

University of Groningen. Improving diagnostic accuracy in aortic prosthetic graft infection Saleem, Rani

Primary graft infections

Graft infection after endovascular abdominal aortic aneurysm repair

LINC James F. McKinsey, M.D.

How we deal with aortic endograft infection. Elena Iborra, Emma Espinar, Ramon Vila Hospital Universitari de Bellvitge Barcelona, Spain

Antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary vascular surgical site infections

Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections

Protect the Neck. Lieven Maene, MD. Marc Bosiers Koen Deloose Joren Callaert. Patrick Peeters Jürgen Verbist. Lieven Maene Roel Beelen.

Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states

Modular branched endograft system for aortic aneurysm repair: evaluation in a human cadaver circulation model

4/25/2009. Other 8% Thrombosis? Stenosis 8% 74% Infection 10%

A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network

KEY TO INNOVATION AT VASCUTEK JAPAN MATTERS FEBRUARY 7TH 2014

University of Groningen. Improving diagnostic accuracy in aortic prosthetic graft infection Saleem, Rani

PREVELEAK Surgical sealant

ANGIOLOGIA E CIRURGIA VASCULAR

Fungal graft infections: Case report and review of the literature

A first-in-man study of the role of flexible robotics in overcoming navigation challenges in the iliofemoral arteries

CTA Throughout the Ages

Antibiotic irrigation and conservative for major aortic graft infection

A preliminary study of prosthesis damage by laser energy. James M. Seeger, M.D., George S. Abela, M.D.,* and Nina Klingman, B.S., Gainesville, Fla.

BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician.

FREQUENTLY ASKED QUESTIONS

MIIG INJECTABLE Graft The following languages are included in this packet:

Continuous External Tissue Expander

High 18 F-FDG Uptake in Synthetic Aortic Vascular Grafts on PET/CT in Symptomatic and Asymptomatic Patients

Prediction of altered endograft path during endovascular abdominal aortic aneurysm repair with the Gore Excluder

Patient-specific simulation of stent-graft deployment within an abdominal aortic aneurysm

EVAR Guided by 3D Image Fusion and CO 2 DSA: A New Imaging Combination for Patients With Renal Insufficiency

Catheter-less angiography for endovascular aortic aneurysm repair: A new application of carbon dioxide as a contrast agent

ENDOVASCULAR STENT GRAFT REPAIR OF THORACIC AORTIC ANEURYSM BRIGHAM & WOMEN'S HOSPITAL BOSTON, MA

FREQUENTLY ASKED QUESTIONS

9/29/2016. Implantable Artificial Kidney: From Silicon Chips to Renal Clearance. ESRD Statistics. Arrhythmia Care as a Paradigm

Presenting SURGICEL Powder

-- Laki J. Rousou, MS, MD et. al. -- Boston, Massachusetts. -- Ann Thorac Surg 2009;87:62 70.

Laminar flow in orthopaedic operations - Essential if you can afford it. Peter Hoffman Consultant Clinical Scientist Public Health England

Advancing minimally invasive. therapeutics through novel device. development. Minima y Invasive New Technologies T H E L E O N A M. A N D H A R R Y B.

TRUFILL DCS ORBIT Detachable Coil System

Thoracoscopic Pneumonectomy. 10 th Annual Masters in Minimally Invasive Thoracic Surgery

Medtronic Life Sciences Case Study

ARTICLE IN PRESS. State-of-the-art - Cardiac general

Mid-term results of the global ANCHOR registry regarding the treatment of type I endoleaks

Autologous transfusion refers to those transfusions in which the blood

Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach

First Experiences with the Ziehm Vision FD Mobile C-Arm with Flat-Panel Detector

The innovation of intraoperative 3D imaging

What makes the technology unique?

Get a Closer Look. Continuing Support

HCT/P Deviations & Reporting. 13 th ANNUAL FDA & The Changing Paradigm for HCT/P Regulation February 13-15, 2017

ALLODERM SELECT ALLODERM SELECT RESTORE

Annual Results Presentation 23 rd May 2016 Ian Jefferson - CFO

RapidPort EZ Port Applier DIRECTIONS FOR USE (DFU)

Zenith TX2 Dissection Endovascular Graft with Pro-Form and the Z-Trak Plus Introduction System

Bioengineered AV Grafts: They Are Finally Happening! Synthetic Vascular Dialysis Grafts. Vascular Grafts and Failure. Disclosure Information

Decide, guide, treat and confirm: The Philips Volcano CLI solution

TRANSFORMING NEUROLOGICAL HEALTHCARE.

RADIATION EXPOSURE IN ENDOVASCULAR PROCEDURES - AN ASSESSMENT BASED ON EXAMINATIONS PERFORMED AT SAHLGRENSKA UNIVERSITY HOSPITAL

Multidisciplinary Treatment Approach for Prosthetic Vascular Graft Infection in the Thoracic Aortic Area

Clinical Applications. ImagingRite. Interventional Radiology

Our Experience with Trinias Biplane and Hybrid Operating Room Systems

Diagnosis for Open Wounds as a Result of Cancer Resection

Learning Objectives include:

During pulmonary resection surgeons occasionally. Use of Three-Dimensional Computed Tomographic Angiography of Pulmonary Vessels for Lung Resections

Albumin-impregnated Polyester Vascular Prosthesis for Abdominal Aortic Surgery: An Improvement?

Policies Concerning Survival Surgery of Mice

Antibiotic prophylaxis in surgery (ADULTS) Type of Surgery Antibiotic of Choice Alternative in true Penicillin Allergy or MRSA carriage

Anti- THrombosis with Enoxaparin in intubated Adolescents

North Carolina Medicaid Special Bulletin

The Clinical Use and Immunologic Impact of Thrombin in Surgery

Tissue Engineering For Regenerating Life. Cryopreserved Products. Tissue Corporation

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

Adjustable Torquer. Collet Cap

PVL en Pacemaker rate problems solved. Tailored patient treatment, with a valve choice best for different anatomical features.

Clinical Applications. ImagingRite. Neuro Intervention. 1 ImagingRite

EndoVascular hybrid Trauma and bleeding Management (EVTM)

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

ICU. Recovery. Plus Ultrasound-guided mechanical ventilation, F. Mojoli & S. Mongodi MANAGEMENT & PRACTICE

Zenith Alpha System, Designed for Easy and Durable repairs. Prof. Elixène JEAN-BAPTISTE (Nice)

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Contains Nonbinding Recommendations Draft - Not for Implementation

Ask your surgeon for more information about Natrelle and visit GummyImplants.com

Applications in Cardiology 3/30/2006 1

An audit on the technique of collection of blood for culture at the National Hospital of Sri Lanka

CapSure Permanent Fixation System

Division of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

Transcription:

University Hospital Parkland Hospital

Contemporary Management of Aortic Graft Infections R. James Valentine, MD Division of Vascular and Endovascular Surgery UT Southwestern Medical Center Dallas, Texas

Outline Presentation and diagnosis Treatment options and outcomes Role for endovascular therapy

Aortic Grafts Widespread use since 1954 Excellent durability Inert material No rejection Susceptible to infection

Aortic Graft Infections Affect 2-3% of all prosthetic grafts Higher in groin incisions Higher in emergency cases

Infection Sources

INTRAOPERATIVE CONTAMINATION Patient Factors Skin edge Redo operations Lymphatics Groin incision

Efficacy of prophylactic antibiotics in vascular surgery: An arterial wall microbiologic and pharmacokinetic perspective S. Lalka, J Malone, D Fisher Jr., V. Bernhard, D Sullivan, D Stoeckelmann, R.Bergstrom N=29 with groin incisions Preoperative antibiotics Samples for culture Serum Subcutaneous fat Atheroma Arterial wall JVS 1989; 10: 501-9

Efficacy of prophylactic antibiotics in vascular surgery: An arterial wall microbiologic and pharmacokinetic perspective S. Lalka, J Malone, D Fisher Jr., V. Bernhard, D Sullivan, D Stoeckelmann, R.Bergstrom 41% had positive arterial cultures 70% S. epidermidis Half slime producers JVS 1989; 10: 501-9

INTRAOPERATIVE CONTAMINATION Patient Factors Remote infection UTI Pneumonia Distal source

INTRAOPERATIVE CONTAMINATION Patient Factors Laminated thrombus 15-20% + cultures 10% s. epidermidis Lymphatics

INTRAOPERATIVE CONTAMINATION Surgeon Factors Hole in glove Break in sterile technique Concomitant procedures Cholecystectomy Appendectomy

INTRAOPERATIVE CONTAMINATION Surgeon Factors N = 40 graft procedures (most aortic) Preoperative antibiotics Randomised to glove change Cultured grafts and gloves Zdanowski et al, Eur J Vasc Endovasc Surg 1999

INTRAOPERATIVE CONTAMINATION Surgeon Factors Culture surgeon gloves & graft material 33% surgeons gloves imprints positive for S. epidermidis 75% grafts positive for S. epidermidis Glove change made no difference 25% of strains resistant to antibiotic!

Classification and Presentation

Aortic Graft Infections Bandyk classification Early (< 4 months) gram + and gram organisms entire graft infected More obvious (cellulitis/sepsis) Late (> 4 months) usually > 1 year after implant S. epidermitis may not involve entire graft More subtle (drainage/psa)

Presentation

Diagnosis of Graft Infection

CT Scan Good for obvious signs: Perigraft fluid/air Pseudoaneurysm Aortic wrap disruption For low-grade infections: 100% specificity 55% sensitivity

MRI Better to detect small fluid collections Can differentiate inflammation vs. hematoma T2 weighted images

Diagnosis of AEF EGD? - Not specific - Not sensitive CTA - Air around graft

Treatment Options

Conservative Management Very sick patients / Critical location Low-virulence organisms Drain infected perigraft space + irrigation Life-long antibiotics

Conservative Management 30 40 % death at one year due to sepsis (cont d) Contraindications AEF Virulent organisms Anastomotic aneurysms

Partial Excision Localized infection Femoral portion Low virulence organisms In situ vs. extraanatomic

Total Graft Excision

Revascularization Options Temporary/unusual Permanent cure Prosthetic graft Extra-anatomic bypass Cryopreserved allograft Autogenous vein Endovascular grafts

Total Excision Extra-Anatomic Bypass

Excision/Ectopic Bypass problems Thrombosis of ectopic bypass -- Primary patency 43% at 3 years -- Limb loss 33% (UCLA series, arch Surg 91) Reinfection of ectopic bypass 15% Aortic stump blowout

Replace with Prosthetic Graft Rifampin-soaked Dacron Silver-impregnated Dacron

Prosthetic Graft limited use! May be appropriate for limited infections Aortoenteric fistula 15-20% reinfection rate Rifampin, Silver impregnated grafts low virulence organisms (10% reinfection) virulent organisms (40% reinfection) Bridge procedure??

Cropreserved Aortic Graft Requires 1-2 days to obtain 30 minute prep time ABO compatibility? Excellent early results Resistant to most infections Easy handling

Cryopreserved Aortic Graft problems Side branch rupture 10-20% acute bleeding Worse outcome in AEF 10-20% late graft failure AEF Pseudoaneurysms

Replace with Autogenous Vein Neo-Aortoiliac System (NAIS) Reconstruction (Clagett Procedure)

Patency (%) Primary Patency Assist Primary/Secondary Patency 100 90 80 70 60 50 40 30 20 10 91% 81.7% 0 0 12 24 36 48 60 72 84 96 Months

Limb Salvage % Limb Salvage 100 90 80 70 92.5% 89.1% 60 50 40 30 20 10 0 0 12 24 36 48 60 72 84 Months

UTSW experience 1990-2011 250 operations 2325 hours 1875 Units transfused Results: 90% patency 90% limb salvage 10% mortality

Endovascular Option theoretically unappealing!

Infected EVAR a new problem

Mycotic AAA: 25% recurrent infection AEF: 44% recurrence at 13 months ABF: 10% recurrence at 12 months

Endovascular Utility? temporary control of bleeding

Salmonella Aortitis Septic Acute MI Ruptured aneurysm Hypotensive

Temporary EVAR Coverage Rapid access to aorta Potential for balloon occlusion EVAR deployed

Temporary EVAR Coverage Immediate BP stable Allowed 6 weeks IV antibiotics MI recovery Cardiac rehab Brought back for definitive Tx

Outcome Complete recovery Returned to work, normal life Graft patent, no reinfection

Summary Aortic graft infections Rare Wide range of presentation Multiple options for treatment Individualize Few = permanent cure Endovascular option = temporary May be life saving!